Article tools
Author information

Articles

The Effect of In Vivo Hydrocortisone on Subpopulations of Human Lymphocytes

Anthony S. Fauci and David C. Dale

1Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014

This study was designed to determine the effect of in vivo hydrocortisone on subpopulations of lymphoid cells in normal humans. Subjects received a single intravenous dose of either 100 mg or 400 mg of hydrocortisone, and blood was drawn at hourly intervals for 6 h, and then again at 10 and 24 h after injection. Profound decreases in absolute numbers of circulating lymphocytes and monocytes occurred at 4-6 h after both 100 mg and 400 mg of hydrocortisone. Counts returned to normal by 24 h. The relative proportion of circulating thymus-derived lymphocytes as measured by the sheep red blood cell rosette assay decreased maximally by 4 h and returned to base line 24 h after hydrocortisone. There was a selective depletion of functional subpopulations of lymphocytes as represented by differential effects on in vitro stimulation with various mitogens and antigens. Phytohaemagglutinin response was relatively unaffected, while responses to concanavalin A were significantly diminished. Responses to pokeweed mitogen were unaffected by 100 mg of hydrocortisone, but greatly diminished by 400 mg of hydrocortisone. In vitro responses to the antigens streptokinase-streptodornase and tetanus toxoid were markedly diminished by in vivo hydrocortisone. Reconstitution of monocyte-depleted cultures with autologous monocytes partially corrected the diminished response to antigens. This transient selective depletion of monocytes and subsets of human lymphocytes by a single dose of hydrocortisone is most compatible with a redistribution of these cells out of the circulation into other body compartments.

Browse pages

Click on an image below to see the page. View PDF of the complete article


Articles that cite this article:

Stress-Induced Enhancement of Cell-Mediated Immunitya
FIRDAUS S. Dhabhar
Ann N Y Acad Sci 840(1 neuroimmunomo):359. doi:10.1111/j.1749-6632.1998.tb09575.x [CrossRef]

Effect of Treatment on T-Cell Function in Chronic Lymphocytic Leukaemia
L. A. Fernandez, J. M. Macsween, G. R. Langley
Br J Haematol 38(2):171. doi:10.1111/j.1365-2141.1978.tb01033.x [CrossRef]

Peripheral blood cell changes in response to acute hypoglycaemia in man
B. M. Frier, R. J. M. Corrall, N. McD. Davidson, R. G. Webber, A. Dewar, E. B. French
Eur J Clin Invest 13(1):33. doi:10.1111/j.1365-2362.1983.tb00061.x [CrossRef]

Phenytoin modulates the pharmacokinetics of prednisolone and the pharmacodynamics of prednisolone as assessed by the inhibition of the mixed lymphocyte reaction in humans
BRIGITTE M. Frey, FELIX J. Frey
Eur J Clin Invest 14(1):1. doi:10.1111/j.1365-2362.1984.tb00695.x [CrossRef]

Effects of methylprednisolone on the Fc-receptor function of human reticuloendothelial system in vivo
CLAIRE Hoyoux, JACQUELINE Foidart, PIERRE Rigo, PHILIPPE Mahieu, FERNAND Geubelle
Eur J Clin Invest 14(1):60. doi:10.1111/j.1365-2362.1984.tb00705.x [CrossRef]

Changes of immunoregulatory cells induced by acoustic stress in patients with systemic lupus erythematosus, sarcoidosis, and in healthy controls
H. Hinrichsen, J. Barth, R. Ferstl, W. Kirch
Eur J Clin Invest 19(4):372. doi:10.1111/j.1365-2362.1989.tb00244.x [CrossRef]

INTRAVENOUS PULSE METHYL PREDNISOLONE IN THE SUCCESSFUL TREATMENT OF SEVERE SARCOID POLYNEUROPATHY WITH PULMONARY INVOLVEMENT
R. K. A. Allen, J. Merory
Intern Med J 15(1):45. doi:10.1111/j.1445-5994.1985.tb02731.x [CrossRef]